CompaniesCytonet

Cytonet

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

1,632

By Phase

PHASE4: 2NA: 3

By Status

RECRUITING: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
NCT03972553
NCT04007952
NCT05599750
NCT05929937
Hover over trial bars to see details

Recent Trials

NCT05985343Lead Sponsor
The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction
PHASE4Active, not recruiting
184 participants
Started: Jan 15, 2024 · Completed: Jun 30, 2025
NCT05929937Lead Sponsor
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
PHASE4Recruiting
904 participants
Started: Jul 10, 2023 · Completed: Jul 31, 2027
NCT05599750Lead Sponsor
Suture Repair vs Mesh Repair for Incisional Hernia
NARecruiting
154 participants
Started: Nov 14, 2022 · Completed: Oct 31, 2031
NCT04007952Lead Sponsor
Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair
NACompleted
240 participants
Started: Jun 26, 2019 · Completed: Feb 28, 2024
NCT03972553Lead Sponsor
Parastomal Hernia Repair Utilizing the Retromuscular Sugarbaker Versus Keyhole Mesh Techniques
NACompleted
150 participants
Started: Apr 25, 2019 · Completed: Nov 27, 2023
Related Companies
Prometera Biosciences
acquired